- Patent Title: Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor
-
Application No.: US17159928Application Date: 2021-01-27
-
Publication No.: US11655248B2Publication Date: 2023-05-23
- Inventor: Yaxian Cai , Zhaobing Xu , Hailong Yang , Shiqi Han , Guoping Hu , Lihong Hu , Charles Z. Ding , Jian Li , Shuhui Chen
- Applicant: MEDSHINE DISCOVERY INC.
- Applicant Address: CN Jiangsu
- Assignee: MEDSHINE DISCOVERY INC.
- Current Assignee: MEDSHINE DISCOVERY INC.
- Current Assignee Address: CN Jiangsu
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: CN 1810055396.8 2018.01.19 CN 1810712103.9 2018.06.29
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61P35/00
Abstract:
Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20210147418A1 Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor Public/Granted day:2021-05-20
Information query
